source
- ADC biotech Ona Therapeutics raises $86.6M in Series B to move two ADC candidates toward clinicBarcelona-based Ona Therapeutics announced a $86.6 million Series B financing round. The capital will be used to move two antibody‑drug conjugate (ADC) programs into early‑stage clinical testing.…
- Trump admin moves to politicize NIH grant officials, stripping job protectionsThe White House issued an executive order that reclassifies thousands of civil‑service positions as political appointments under the so‑called Schedule F. The change would allow the administration…